Paymentus Holdings, Inc. financial statements

Income statement, balance sheet and cash flow statement for the last 7 fiscal years, taken from the XBRL data Paymentus Holdings, Inc. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2019	FY2021	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	236	302	396	497	614	872	1,197
Cost of revenue	161	209	274	347	432	634	900
Gross profit	74.4	92.6	121	150	182	238	296
Research and development	17.9	24.5	34.1	41.2	44.2	51.3	61.5
Selling and marketing	28	31.8	43.9	73.3	84	105	112
General and administrative	10.2	17.8	33	38.1	36	36.9	47.4
Operating expenses	56.1	74.2	111	153	164	193	221
Operating income	18.4	18.4	10.4	-2.98	18.1	44.9	75.5
Other non-operating income				0.01	0.01	0.35	0.23
Pre-tax income	18.5	18.4	10.4	-1.31	25.1	53.9	85.3
Income tax	4.78	4.65	1.07	-0.8	2.8	9.78	18.3
Net income	13.7	13.7	9.3	-0.51	22.3	44.2	66.9
EBITDA	24.4	26.5	23.7	21.1	48.7	81.3	117
EPS, basic	0.09	0.08	0.06	0.00	0.18	0.36	0.53
EPS, diluted	0.08	0.08	0.06	0.00	0.18	0.35	0.52
Shares, basic (weighted)	103	103	113	122	124	124	125
Shares, diluted (weighted)	106	106	119	122	125	128	129

Balance sheet

	FY2019	FY2021	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	27.4	46.7	168	147	179	206	321
Other current assets		3.12	8.18	9.99	10.5	13.1	13.2
Total current assets		79.8	256	229	270	346	441
Property, plant and equipment		1.77	2.04	1.82	1.56	1.16	0.88
Lease right-of-use assets		8.32	7.7	9.56	10	7.8	6.38
Goodwill	13.2	13.2	129	132	132	132	132
Intangible assets		0.3	42.1	36	27.2	19.1	12
Other non-current assets		0.22	4.21	7.18	5.03
Total assets		125	473	462	505	576	668
Accounts payable		16.8	24.7	29.2	35.2	49.9	64
Accrued liabilities		10.2	12.5	15.8	21.3	26.5	28.4
Deferred revenue		0.61	2.17	4.36	4.09	2.94	3.5
Total current liabilities		31.1	74.4	51.5	62.8	81.6	98.8
Lease liabilities		5.48	6.46	8.61	8.66	6.32	4.56
Total liabilities		40.5	86.8	64.4	75.2	90.7	107
Paid-in capital		29.2	356	368	378	390	398
Retained earnings		55	29.9	29.4	51.7	95.9	163
Treasury stock		-0.58	0
Other comprehensive income		0.22	0.17	-0.02	0.09	-0.23	-0.43
Shareholders' equity	68.6	84.4	386	397	430	486	560
Total equity	68.6	84.4	386	397	430	486	560
Total liabilities and equity		125	473	462	505	576	668
Shares outstanding		103	0

Cash flow statement

	FY2019	FY2021	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	13.7	13.7	9.3	-0.51	22.3	44.2	66.9
Depreciation and amortization	6	8.07	13.3	24.1	30.6	36.5	41.1
Stock-based compensation	1.59	1.99	3.14	6.74	9.39	11	18.6
Deferred income tax	1.28	1.63	-0.66	-2.97	0.41	-1.35	0.05
Change in payables	-0.6	14.6	7.38	4.77	6.02	13.8	14
Cash from operations	17.5	35.6	19.5	19.9	68.8	63.6	162
Capital expenditures	-1.04	-0.46	-0.98	-1.26	-0.6	-0.46	-0.36
Acquisitions	-1.37	0.29	-57.4	-3.26	0	0
Cash from investing	-13.9	-15.1	-77.8	-34.6	-34.3	-36.8	-36.5
Stock issued	0.06	0	0.32	1.49	0.62	0.34	0.16
Cash from financing	-0.86	-1.36	213	-37.3	-1.2	-0.21	-10.6
Exchange rate effect	0.04	0.11	-0.01
Net change in cash	2.79	19.2	155	-52.1	33.5	26.2	115
Free cash flow	16.5	35.2	18.5	18.6	68.2	63.2	162
Income taxes paid	4.74	2.89	2.49	0.67	1.4	14.4	15

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $30.17 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	24.9%	Gross profit / revenue.
Operating margin	7.6%	Operating income / revenue.
EBITDA margin	9.0%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	8.4%	Pre-tax income / revenue.
Net margin	6.2%	Net income / revenue.
FCF margin	11.7%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	11.7%	Cash from operations / revenue.
Effective tax rate	25.5%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	13.8%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	11.7%	Net income / average total assets.
Return on invested capital (ROIC)	32.6%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue	4.6%	Research and development expense / revenue.
Stock-based pay / revenue	1.8%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	0.0%	Capital expenditures / revenue.
D&A / revenue	1.5%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	37.3%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	34.0%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	31.7%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	24.4%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	25.6%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	26.2%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	68.4%	Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 5y	32.6%	Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y	43.3%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	76.8%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y	34.5%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y	51.5%	Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 5y	37.3%	Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y	48.6%	EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 5y	45.4%	Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	154.8%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	101.3%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	35.4%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y	156.1%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y	105.6%	Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y	35.7%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	15.4%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	12.2%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	46.0%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	15.9%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	13.1%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	39.8%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	1.1%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	1.9%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	4.0%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	4.89x	Current assets / current liabilities.
Quick ratio	3.73x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	3.73x	(Cash + short-term investments) / current liabilities.
Liabilities / assets	15.4%	Total liabilities / total assets.
Working capital	$393.3M	Current assets - current liabilities.
Goodwill and intangibles / assets	19.6%	(Goodwill + intangible assets) / total assets.
Tangible book value	$471.3M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	1.88x	Revenue / average total assets.
Fixed asset turnover	587x	Revenue / average property, plant and equipment.
Days payables	25 days	365 x average accounts payable / cost of revenue.
FCF conversion	187.5%	Free cash flow / net income, when net income is positive.
Capex / operating cash flow	0.2%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$0.66	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$10.55	Revenue / diluted weighted shares.
FCF per share	$1.23	Free cash flow / diluted weighted shares.
Operating cash flow per share	$1.24	Cash from operations / diluted weighted shares.
Book value per share	$4.76	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$3.65	Tangible book value / shares outstanding.
Cash per share	$2.93	(Cash + short-term investments) / shares outstanding.

Valuation

Metric	Value	How it is calculated
Market cap	$3.80B	Share price x shares outstanding.
Enterprise value	$3.42B	Market cap + total debt - cash - short-term investments.
P/E	44.8x	Market cap / net income. Only when net income is positive.
P/S	2.79x	Market cap / revenue.
P/B	6.19x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	8.06x	Market cap / tangible book value, when positive.
P/FCF	23.9x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	23.8x	Market cap / cash from operations, when positive.
EV/Sales	2.52x	Enterprise value / revenue.
EV/EBIT	33.2x	Enterprise value / operating income, when both are positive.
EV/EBITDA	27.8x	Enterprise value / EBITDA, when both are positive.
EV/FCF	21.5x	Enterprise value / free cash flow, when both are positive.
FCF yield	4.2%	Free cash flow / market cap.
Earnings yield	2.2%	Net income / market cap (the inverse of P/E).

What was Paymentus Holdings, Inc.'s revenue in fiscal 2025?

Paymentus Holdings, Inc. reported revenue of $1.20B for fiscal 2025, 37.3% higher than the year before.

Was Paymentus Holdings, Inc. profitable in fiscal 2025?

Yes. Net income was $66.9M, a net margin of 5.6%.

How much free cash flow did Paymentus Holdings, Inc. generate in fiscal 2025?

Cash from operations of $162.1M minus capital expenditures of $361.0K left free cash flow of $161.8M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to Paymentus Holdings, Inc.